Literature DB >> 9468373

Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.

F W Wit, C J Sol, N Renwick, M T Roos, S T Pals, R van Leeuwen, J Goudsmit, P Reiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9468373

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

1.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Immune disorders and susceptibility to neoplasms.

Authors:  Om Prakash; Javed Gill; Gist Farr
Journal:  Ochsner J       Date:  2002

3.  High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Deirdre O'Mahony; Kathleen M Wyvill; Victoria Wang; Vickie Marshall; Stefania Pittaluga; Seth M Steinberg; Giovanna Tosato; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

4.  Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.

Authors:  R Tedeschi; M Enbom; E Bidoli; A Linde; P De Paoli; J Dillner
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  High Glucose Induces Reactivation of Latent Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Fengchun Ye; Yan Zeng; Jingfeng Sha; Tiffany Jones; Kurt Kuhne; Charles Wood; Shou-Jiang Gao
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

6.  Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.

Authors:  J Goudsmit; N Renwick; N H Dukers; R A Coutinho; S Heisterkamp; M Bakker; T F Schulz; M Cornelissen; G J Weverling
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: a cross-sectional study.

Authors:  Christopher De Boer; Nixon Niyonzima; Jackson Orem; John Bartlett; S Yousuf Zafar
Journal:  Infect Agent Cancer       Date:  2014-05-20       Impact factor: 2.965

8.  Histological variants of cutaneous Kaposi sarcoma.

Authors:  Wayne Grayson; Liron Pantanowitz
Journal:  Diagn Pathol       Date:  2008-07-25       Impact factor: 2.644

9.  Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes.

Authors:  Abeltje M Polstra; J Goudsmit; M Cornelissen
Journal:  BMC Infect Dis       Date:  2002-09-04       Impact factor: 3.090

10.  Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.

Authors:  JM Bollen; AM Polstra; AC Van Der Kuyl; JF Weel; LA Noorduyn; MHJ Van Oers; M Cornelissen
Journal:  BMC Blood Disord       Date:  2003-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.